IDEXX Laboratories, Inc. (IDXX) income statement
NASDAQ · Healthcare · Medical - Diagnostics & Research · 11,000 employees · CEO Michael Erickson
- Price
- $698.55 +3.94%
- Market cap
- $55B
- Enterprise value
- $55.8B
- Last report
- Q3 '26 filed 2026-11-02
- Next report
- 2027-02-01 EPS est. $3.33
IDEXX Laboratories, Inc. (IDXX) reported revenue of $1.21B for Q3 '26 (+9.9% year on year), operating income of $402M (33.1% of revenue) and net income of $317M. Over the last four quarters revenue was $4.66B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $902M | $964M | $1B | $976M | $954M | $998M | $1.11B | $1.11B | $1.09B | $1.14B | $1.22B | $1.21B | |
| Cost of revenue | $375M | $371M | $383M | $380M | $384M | $375M | $415M | $422M | $432M | $418M | $437M | $450M | |
| Gross profit | $526M | $593M | $621M | $596M | $571M | $623M | $695M | $683M | $658M | $723M | $779M | $764M | |
| Research & development | $51.8M | $52.6M | $55.5M | $54M | $57.7M | $59.1M | $61.9M | $63.4M | $66.8M | $65.8M | $65.4M | $68.8M | |
| Sales & marketing | $142M | $149M | $143M | $146M | $150M | $156M | $161M | $159M | $167M | $175M | $171M | $170M | |
| General & administrative | $87M | $92M | $157M | $91.9M | $101M | $91.6M | $98.7M | $106M | $109M | $119M | $117M | $123M | |
| Operating expenses | $281M | $294M | $355M | $292M | $309M | $307M | $322M | $329M | $343M | $360M | $354M | $362M | |
| Operating income | $245M | $299M | $264M | $304M | $262M | $317M | $373M | $355M | $316M | $363M | $426M | $402M | |
| Interest income | $3.63M | $4.43M | $3.35M | $2.71M | $2.2M | $1.22M | $627K | $580K | $587K | $597K | $606K | $967K | |
| Interest expense | $9.27M | $7.91M | $8.1M | $7.7M | $7.5M | $7.67M | $11.3M | $10.7M | $10.5M | $7.74M | $10.2M | $7.46M | |
| Other non-operating income (gains on investments, FX ...) | -$3.63M | -$4.43M | -$3.35M | -$2.71M | -$2.2M | -$1.22M | -$627K | -$580K | -$1.89M | -$597K | -$1.84M | -$4.44M | |
| Total non-operating income | -$5.63M | -$3.48M | -$4.75M | -$4.98M | -$5.3M | -$6.45M | -$10.7M | -$10.1M | -$8.62M | -$7.14M | -$8.34M | -$3.02M | |
| Income before tax | $240M | $295M | $259M | $299M | $256M | $310M | $362M | $345M | $307M | $355M | $417M | $399M | |
| Income tax | $45.1M | $59.9M | $55.8M | $66.1M | $40.2M | $67.4M | $68.4M | $70.2M | $58.8M | $77M | $78.8M | $82.2M | |
| Net income | $195M | $236M | $203M | $233M | $216M | $243M | $294M | $275M | $248M | $278M | $338M | $317M | |
| EPS (basic) | $2.34 | $2.84 | $2.46 | $2.83 | $2.63 | $2.98 | $3.66 | $3.43 | $3.10 | $3.48 | $4.23 | $4.02 | |
| EPS (diluted) | $2.32 | $2.81 | $2.44 | $2.80 | $2.62 | $2.96 | $3.63 | $3.40 | $3.08 | $3.45 | $4.19 | $4.01 | |
| Shares (basic, weighted) | 83.1M | 83.1M | 82.6M | 82.3M | 81.8M | 81.3M | 80.4M | 80.1M | 80.1M | 80.1M | 80.1M | 78.8M | |
| Shares (diluted, weighted) | 83.9M | 84M | 83.4M | 83.1M | 82.5M | 81.9M | 81M | 80.7M | 80.7M | 80.7M | 80.7M | 79M | |
| Depreciation & amortization | $29.7M | $29.9M | $32.2M | $34.1M | $33.7M | $34.1M | $35.8M | $36.6M | $38.7M | $37.7M | $41.1M | $40.6M | |
| EBITDA | $279M | $335M | $301M | $342M | $299M | $352M | $409M | $392M | $356M | $401M | $468M | $447M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.78B | $1.97B | $2.21B | $2.41B | $2.71B | $3.22B | $3.37B | $3.66B | $3.9B | $4.3B | |
| Cost of revenue | $800M | $872M | $972M | $1.04B | $1.14B | $1.33B | $1.36B | $1.47B | $1.52B | $1.64B | |
| Gross profit | $975M | $1.1B | $1.24B | $1.37B | $1.57B | $1.89B | $2B | $2.19B | $2.38B | $2.66B | |
| Research & development | $101M | $109M | $118M | $133M | $141M | $161M | $255M | $191M | $220M | $251M | |
| Sales & marketing | $317M | $354M | $387M | $418M | $434M | $487M | $525M | $566M | $589M | $644M | |
| General & administrative | $207M | $221M | $245M | $261M | $301M | $310M | $326M | $336M | $442M | $405M | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $1.46M | $2.2M | $0 | $0 | $0 | |
| Operating expenses | $625M | $684M | $750M | $813M | $877M | $957M | $1.11B | $1.09B | $1.25B | $1.3B | |
| Operating income | $350M | $413M | $491M | $553M | $695M | $932M | $899M | $1.1B | $1.13B | $1.36B | |
| Interest income | $3.66M | $5.25M | $1.15M | $427K | $586K | $434K | $1.07M | $5.63M | $12.7M | $2.42M | |
| Interest expense | $32M | $37.2M | $34.7M | $31.1M | $33.1M | $29.8M | $39.9M | $41.6M | $31.2M | $38.3M | |
| Other non-operating income (gains on investments, FX ...) | -$3.66M | -$5.25M | -$1.15M | -$427K | -$586K | -$434K | -$1.07M | -$5.63M | -$12.7M | -$2.42M | |
| Total non-operating income | -$28.4M | -$32M | -$33.6M | -$30.6M | -$32.5M | -$29.4M | -$38.8M | -$36M | -$18.5M | -$35.8M | |
| Income before tax | $322M | $381M | $458M | $522M | $662M | $903M | $860M | $1.06B | $1.11B | $1.32B | |
| Income tax | $99.8M | $118M | $80.7M | $94.4M | $79.9M | $158M | $181M | $216M | $222M | $265M | |
| Net income | $222M | $263M | $377M | $428M | $582M | $745M | $679M | $845M | $888M | $1.06B | |
| EPS (basic) | $2.47 | $3.00 | $4.34 | $4.97 | $6.82 | $8.74 | $8.12 | $10.17 | $10.77 | $13.17 | |
| EPS (diluted) | $2.44 | $2.94 | $4.26 | $4.89 | $6.71 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 | |
| Shares (basic, weighted) | 89.7M | 87.8M | 86.9M | 86.1M | 85.3M | 85.2M | 83.6M | 83.1M | 82.5M | 80.1M | |
| Shares (diluted, weighted) | 90.9M | 89.6M | 88.5M | 87.5M | 86.7M | 86.6M | 84.6M | 84M | 83.2M | 80.7M | |
| Depreciation & amortization | $78.2M | $83.1M | $83.2M | $88M | $96M | $105M | $112M | $115M | $130M | $145M | |
| EBITDA | $432M | $501M | $576M | $644M | $794M | $1.04B | $1.01B | $1.22B | $1.28B | $1.51B |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-05